INS and type 2 diabetes mellitus: Given the clear impact on type 2 diabetes among heterozygous carriers, distinct from typical forms of type 2 diabetes, it is critical to understand the molecular mechanism behind the switch from hypersecretion of insulin during in utero development and infancy to impairment in insulin secretion, which is a hallmark of type 2 diabetes, at later ages.